Mark Preston
Impact in
-
- Aortic Disease and Treatment Approaches
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Aortic aneurysm repair treatments
-
- Cardiac Valve Diseases and Treatments
Papers in ⓘ
-
- Prostate Cancer Treatment and Research 9
- Prostate Cancer Diagnosis and Treatment 8
- Renal cell carcinoma treatment 3
-
- Urologic and reproductive health conditions 4
- Co-authors
- Piroze Davierwala (1 shared paper)Susan Armstrong (1 shared paper)Paul W.M. Fedak (1 shared paper)Joan Ivanov (1 shared paper)Tirone E. David (1 shared paper)Michael A. Borger (1 shared paper)Rodney H. Breau (8 shared papers)Lorelei A. Mucci (7 shared papers)
- Journals
- The Journal of Urology (4 papers)ACS Synthetic Biology (2 papers)Journal of Clinical Oncology (2 papers)European Urology (2 papers)Urologic Oncology Seminars and Original Investigations (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Mark Preston
24 papers receiving 659 citations
Peers
Comparison fields: 5 of 68
- Pulmonary and Respiratory Medicine 430
- Cardiology and Cardiovascular Medicine 244
- Urology 60
- Rheumatology 100
- Epidemiology 150
Countries citing papers authored by Mark Preston
This map shows the geographic impact of Mark Preston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Preston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Preston more than expected).
Fields of papers citing papers by Mark Preston
This network shows the impact of papers produced by Mark Preston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Preston. The network helps show where Mark Preston may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Preston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 246 | |
| 2 | 2014 | 109 | |
| 3 | 2013 | 59 | |
| 4 | 2014 | 51 | |
| 5 | 2011 | 46 | |
| 6 | 2010 | 31 | |
| 7 | 2014 | 30 | |
| 8 | 2010 | 23 | |
| 9 | 2015 | 15 | |
| 10 | 2015 | 15 | |
| 11 | 2014 | 12 | |
| 12 | 1984 | 10 | |
| 13 | 2019 | 6 | |
| 14 | 2014 | 6 | |
| 15 | 2023 | 4 | |
| 16 | 2011 | 4 | |
| 17 | 2016 | 3 | |
| 18 | 2013 | 3 | |
| 19 | 2013 | 3 | |
| 20 | 2024 | 2 |
About Mark Preston
Mark Preston is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Urology, Reproductive Medicine and Surgery, having authored 28 papers that have together received 684 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (8 papers), Urologic and reproductive health conditions (4 papers), Cancer, Lipids, and Metabolism (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Renal cell carcinoma treatment (3 papers), Surgical Simulation and Training (3 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (430 citations), Cardiology and Cardiovascular Medicine (244 citations), Urology (60 citations), Rheumatology (100 citations) and Epidemiology (150 citations). Mark Preston has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Piroze Davierwala, Susan Armstrong, Paul W.M. Fedak, Joan Ivanov, Tirone E. David, Michael A. Borger, Rodney H. Breau, Lorelei A. Mucci, Evgeniy Kreydin and Glen W. Barrisford. Their work appears in journals such as The Journal of Urology, ACS Synthetic Biology, Journal of Clinical Oncology, European Urology and Urologic Oncology Seminars and Original Investigations.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.